As of December 2021, the U.S. Government has allocated more than $75.5 million in new resources and two million doses of Pfizer-BioNTech vaccines to assist Peru in its emergency response to COVID-19. The aid continues a strong history of investing in Peru’s health care systems and long-term development, mainly through the U.S. Agency for International Development (USAID).
Ongoing U.S. Government-funded programs and partners are also adapting activities to respond to this unprecedented crisis. Over the last 20 years, U.S. assistance to Peru totals more than $3.5 billion, including $265 million in the health sector. Emergency assistance comes from the U.S. Agency for International Development (USAID), the Department of Defense Humanitarian Assistance Program, and the Department of State’s Emergency Refugee and Migration Assistance fund..